IL6 and pancreatic ductal adenocarcinoma: Penny and colleagues also reported that pancreatic ductal adenocarcinoma produced TAMs expressing both M1 (IL‐1β, IL6, and TNF‐α) and M2 (CD163, CD206, and Arg1) markers.27